Excision
Founded 2015 · $60.0M raised
- Founded
- 2015
- Business Model
- B2B
- Total Funding
- $60.0M
- Last Round
- $60.0M Series AFeb 2021
- Rounds
- 1
About
Gene editing therapeutics company
Summary
Excision is a Biotech company, founded in 2015. It has raised $60.0M in total across 1 round, most recently a $60.0M Series A round in Feb 2021. Investors include GreatPoint Ventures, Artis Ventures (AV) and Adjuvant Capital.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2021
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company